AMGN vs EGAN · P/E 24, rev $36.75B vs P/E 68, rev $88.4M
Amgen Inc (AMGN) versus eGain Corporation (EGAN) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
eGain Corporation (EGAN) is a software - application company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EGAN revenue for 2025-06-30 was $88.4M. Net income was $32.3M. Revenue was up 293.7% from 2024-06-30 to 2025-06-30. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
Not investment advice. Open the AMGN and EGAN stock pages for the full models.
Not investment advice.